CMS Energy Free cash flow increased by 47.4% to -$334.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 398.2%, from $112.00M to -$334.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.00M | -$448.00M | -$298.00M | $187.00M | -$216.00M | -$1.04B | -$448.00M | $423.00M | $343.00M | $26.00M | -$502.00M | $112.00M | -$470.00M | -$635.00M | -$334.00M |
| QoQ Change | — | -581.7% | +33.5% | +162.8% | -215.5% | -382.4% | +57.0% | +194.4% | -18.9% | -92.4% | <-999% | +122.3% | -519.6% | -35.1% | +47.4% |
| YoY Change | — | — | — | — | -332.3% | -132.6% | -50.3% | +126.2% | -18.9% | — | — | -67.3% | <-999% | -26.5% | -398.2% |